Rituximab Vasculitis Maintenance Study

Clinical trial NCT01697267 · COMPLETED

Trial details

NCT number: NCT01697267
Sponsor: Cambridge University Hospitals NHS Foundation Trust
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Microscopic Polyangiitis Wegener Granulomatosis

Start date: 2013-04-01
Primary completion: 2018-11-22
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.